Structural Optimization and Structure-Activity Relationship of 1-Pyrazole-4-carboxylic Acid Derivatives as DNA 6mA Demethylase ALKBH1 Inhibitors and Their Antigastric Cancer Activity.

DNA -methyladenine (6mA) demethylase ALKBH1 plays an important role in various cellular processes. Dysregulation of ALKBH1 is associated with the development of some cancer types, including gastric cancer, implicating a potential therapeutic target. However, there is still a lack of potent ALKBH1 inhibitors. Herein, we report the discovery of a highly potent ALKBH1 inhibitor, 1-pyrazole-4-carboxylic acid derivative . The structure-activity relationship of this series of compounds was also discussed. Because of the poor cell membrane permeability of , we prepared a prodrug of (), which showed excellent cellular activities. In gastric cancer cell lines HGC27 and AGS, treatment significantly increased the abundance of 6mA, inhibited cell viability, and upregulated the AMP-activated protein kinase (AMPK) signaling pathway. In addition, the hydrolysis product showed high exposure in mice after administration of . Collectively, this research provides a new potent ALKBH1 inhibitor, which could serve as a lead compound for subsequent drug development.